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Introduction: Sexually transmitted infections are among the most frequent infections affecting pregnant women. We assessed the transmission 
of hepatitis B virus, human immunodeficiency virus type 1 and Treponema pallidum to newborns from infected parturients. 
Methodology: An observational, cross-sectional, analytical facility-based survey was conducted among 57 newborns in Irene Neto Maternity, 
Lubango city, Huíla province, Angola. Hepatitis B virus DNA molecular identification was done through nested PCR. Human 
immunodeficiency virus type 1 proviral DNA detection was carried out by two successive nested PCRs. Real-time PCR was performed to 
examine the presence of T. pallidum DNA. Amplicons from PCR positive samples were sequenced for identity search and genotype assignment. 
Results: Hepatitis B virus DNA genotype E was detected in 3/41 (7.3%) newborns from HBsAg (hepatitis B surface antigen) positive mothers. 
To analyse the association between mothers HBeAg (hepatitis B e antigen) positivity and hepatitis B virus vertical transmission to newborns, 
a Fisher's exact test was performed, showing a highly significant association (p = 0.006). Human immunodeficiency virus type 1 provirus or T. 
pallidum DNA was not detected in any newborn. 
Conclusions: To prevent hepatitis B virus vertical transmission in Angola it is important to promote universal antenatal screening, expanding 
hepatitis B virus markers (viral load and/or HBeAg), risk-based infected mothers’ antiviral therapy and newborn passive immunoprophylaxis. 
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Introduction 
Infections remain a major cause of maternal and 
fetal morbidity and mortality worldwide. Antenatal 
screening is essential in managing infections, as well as 
to prevent pathogen vertical transmission (VT). 
Sexually transmitted infections (STI) are among the 
most frequent infections affecting pregnant women [1]. 
The risk of hepatitis B virus (HBV) VT is estimated to 
be higher than 90% when maternal viral load is greater 
than 105 copies/mL, 70-90% in HBeAg (hepatitis B e 
antigen) positive and 10-40% in HBeAg-negative 
mothers [2]. Human immunodeficiency virus (HIV) VT 
rates range from 20-45% without intervention [3]. 
Untreated women have a 70% chance of transmitting 
syphilis to their fetus during the first four years of 
infection [4]. 
In Angola, studies on STI during pregnancy and VT 
are scarce. We assessed the transmission of HBV, HIV-
1 and Treponema pallidum to newborns from infected 
parturients admitted to Irene Neto Maternity (INM), 




An observational, cross-sectional, analytical 
facility-based survey was conducted among 500 
parturients at INM, from October 2016 to September 
2017 [5]. INM is the reference maternity in Huíla, the 
second most populous province in Angola.  
 
Sample Characterization 
Blood samples were obtained from 57 newborns of 
36, 12, four and two mothers infected with HBV, HIV-
1, T. pallidum and HBV/HIV-1, respectively [5]. There 
were three twin pregnancies among the former, 
totalizing 41 newborns from HBV-infected mothers. 
Maternal HBV infection was defined by HBsAg 
(hepatitis B surface antigen) positivity in a rapid test 
(Laboquick HBsAg Test, Koroglu Medical Devices 
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Ltd., Turkey). An algorithm with three rapid tests was 
used for maternal HIV-1 diagnosis: first-line assay was 
a fourth-generation test (DetermineTM HIV-1/2 Ag/Ab 
Combo, Alere Ltd., UK) and the other assays were 
third-generation tests (Hexagon HIV, Human, Germany 
and Info Anti-HIV 1/2, Türklab, Turkey). Inconclusive 
results were confirmed by Western blot (GenscreenTM 
HIV-1/2 Version 2, Bio-Rad, France). Maternal T. 
pallidum antibodies were screened with a treponemal 
rapid test (Laboquick Anti-Syphilis Test, Koroglu 
Medical Devices Ltd., Turkey) and, when reactive, the 
result was confirmed with RPR (Syphilis RPR Test, 
Human, Germany) [5]. We also performed HBeAg 
detection in 33/38 HBsAg-positive mothers (HBe 
Ag&Ab, DIA.PRO, Italy). 
 
Molecular Identification of HBV, HIV-1 and T. 
pallidum in Newborns 
Shortly after birth, a single capillary blood sample 
was collected from each newborn through foot heel 
puncture and conserved in filter paper (Grade 2, 
Whatman, UK). A QIAamp DNA Mini Kit (Qiagen, 
Germany) was used for DNA extraction and 
purification, according to manufacturer’s instructions.  
Molecular identification of HBV DNA was 
conducted through nested PCR targeting a 342 bp 
highly conserved fragment of the genome S/P region, as 
described by Oluyinka et al. [6]. HIV-1 proviral DNA 
detection was carried out by two successive nested 
PCRs for amplification of protease and reverse 
transcriptase coding regions (460 and 650 bp, 
respectively) [7]. Real-time PCR was performed to 
examine the presence of T. pallidum DNA, using 
primers targeting DNA polymerase I (polA) gene and a 
TaqMan probe [8], both designed by TIB MOLBIOL 
(Germany). A commercial reaction mix (NZYSpeedy 
qPCR Probe Master Mix, NZYTech, Portugal) was 
used and amplification was carried out in a Rotor-Gene 
3000 (Corbett, Australia) thermal cycler.  
Amplicons from PCR positive samples were sent to 
STAB VIDA (Portugal) to be sequenced (Sanger) in 
both directions (forward and reverse). The 
complementary sequences were edited in BioEdit 
Sequence Alignment Editor (v.7.0.9.0.) and submitted 
to NCBI BLASTn (Basic Local Alignment Search 
Tool) for identity search and genotype assignment. 
 
Statistical Analysis 
To analyse the association between mothers HBeAg 
positivity and HBV VT to newborns, a Fisher's exact 
test was performed, at the 1% level of significance, 
using SPSS (Statistical Package for the Social Sciences) 
software v.26.  
 
Ethical Considerations 
Parturients signed an informed consent form to be 
included in this study, which was approved by the 
Angola Ethics Committee (No. 35/2017).  
 
Results 
HBV DNA genotype E was detected in 3/41 (7.3%) 
newborns from HBsAg-positive mothers. None of the 
corresponding three parturients was coinfected with 
HIV-1 and only one had been aware of her HBV 
infection, but neither her viral load was evaluated, nor 
did she receive antiviral therapy (AVT).  
HBeAg was detected in 2/33 HBsAg-positive 
mothers (6.1%). These transmitted the infection to their 
newborns (100%), while of the 31 HBeAg-negative, 
only one transmitted the infection (3.2%). There was an 
association between mothers HBeAg positivity and 
HBV VT to newborns (p=0.006). 
HIV-1 provirus or T. pallidum DNA was not 
detected in any newborn from infected mothers. 
Regarding the 14 mothers infected with HIV-1, the 
majority (71.4%) received antiretroviral therapy (ART) 
before and/or during pregnancy and/or intrapartum 
(data on specific antiretrovirals largely incomplete), but 
four (28.6%) did not receive any ART. Among the four 
mothers infected with T. pallidum (RPR titers 1:2-1:8), 
one did not present her pregnancy card, two had a 
negative antenatal screening and one was treated with 
one dose of benzathine penicillin G at 14 weeks of 
pregnancy along with her partner.  
 
Discussion 
Prevention of VT is a major issue to consider in the 
management of STI during pregnancy. VT is related to 
adverse pregnancy outcomes, particularly in resource-
limited countries, where access to adequate antenatal 
care is scarce. To our knowledge, this is one of the few 
reports on VT in Angola, the first on hepatitis B and 
syphilis. 
Regarding HBV VT, the risk is higher in HBeAg-
positive mothers (70-90%) [2]. In our study, despite the 
small numbers involved, a HBV VT rate of 100% in 
HBeAg-positive versus 3.2% in HBeAg-negative 
mothers was found, with an association between 
mothers’ HBeAg and HBV VT to newborns (p = 
0.006), as described before. For example, for Africa, a 
study previously conducted in Cameroon reported 
HBeAg as a serum marker associated with HBV VT [9]. 
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Prevention of HBV VT includes universal antenatal 
screening, maternal AVT if high viral load is present 
and immunoprophylaxis in infants born to infected 
mothers. Evidence on the impact of HBeAg positivity 
must be taken into account when designing policies 
concerning prevention of HBV VT, particularly in low 
and middle-income countries. For instance, Lu et al. 
[10] suggested that vaccine alone may be enough for 
preventing HBV transmission in neonates of HBsAg-
positive/HBeAg-negative mothers. Furthermore, 
Ségéral et al. [11] found that an algorithm of HBsAg 
and HBeAg rapid diagnostic tests could be a low-cost 
strategy to identify HBV-infected pregnant women at 
risk of VT when DNA quantification is not routinely 
available. Although universal HBV vaccination at birth 
is implemented in INM, other measures to prevent HBV 
VT in Lubango are missing. Only one of the three 
parturients with HBV DNA positive newborns had been 
aware of her HBV infection, but viral load had not been 
evaluated and AVT had not been administered. It is 
important to highlight that HBV VT remains a major 
source of perpetuation of chronically infected 
individuals’ reservoir, having a huge impact in 
countries with a high burden of disease, as Angola, a 
country with a reported high HBV carrier rate of 15.1% 
[12]. 
There are several HBV genotypes, with distinct 
geographical distributions. They are important 
epidemiological markers, but they can also influence 
transmission patterns and clinical outcomes. In our 
study, the three HBV DNA positive newborns were 
infected with genotype E. In Angolan patients, this 
genotype is highly predominant [12,13], but genotypes 
A and D have also been reported [12].  
HIV-1 provirus or T. pallidum DNA was not 
detected in any newborn from infected mothers. 
Regarding HIV-1, VT rate can be reduced to well below 
5% with effective interventions [3]. We evaluated HIV-
1 VT in 14 infected mothers with no data on viral load 
and absence of any preventive intervention was 
observed in four of them. High HIV-1 genetic diversity 
in Angola is also a challenge for molecular diagnosis 
[14]. Concerning T. pallidum VT among four infected 
mothers, there was almost no disease history available. 
They presented low nontreponemal titers (1:2-1:8), 
which could suggest the possibility of a serofast syphilis 
or recent treated syphilis, among others, and could 
explain the absence of congenital syphilis cases. 
Among major limitations of this study, one should 
refer that it did not include women giving birth at home, 
which is very frequent in Angola, and maternal occult 
HBV infection was not evaluated. 
Conclusions 
Our study identified three cases of HBV genotype 
E VT, from mothers who were not properly managed 
during pregnancy regarding its prevention. In addition, 
a highly significant association between mothers 
HBeAg positivity and HBV VT to newborns was found. 
To prevent HBV VT in Angola it is important to 
promote universal antenatal HBV screening, expanding 
HBV markers (viral load and/or HBeAg), risk-based 
infected mothers’ AVT and newborn passive 
immunoprophylaxis. A stronger integrated 
multisectoral commitment and further research are 
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